Monday, October 18, 2010

Aldagen Names New CEO

Lyle Hohnke is now the CEO for Aldagen, a clinical-stage biopharmaceutical company based in Durham.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)